Based on all previous observations on pancreatic, colorectal and NSCLC tumours in different world-wide population samples, we interpret that KRAS somatic mutations frequency is very much a population specific phenomenon which definitely is reminiscent of the fact that “one size fits all” population idea may not be valid here too. The gene discussed is KRAS; the disease is neoplasm.